Vicarious Surgical (RBOT) Net Income towards Common Stockholders (2020 - 2025)

Vicarious Surgical (RBOT) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$11.1 million the latest figure, recorded in Q3 2025.

• In Q3 2025, Net Income towards Common Stockholders rose 35.3% year-over-year to -$11.1 million; the TTM figure through Dec 2025 stood at -$39.7 million (up 37.26% YoY), while the FY2024 annual figure was -$63.2 million, up 11.04% from the prior year.
• Net Income towards Common Stockholders rose to -$11.1 million in Q3 2025 per RBOT's latest filing, from -$13.2 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $42.5 million in Q1 2022 and bottomed at -$45.1 million in Q3 2021.
• Historically, Net Income towards Common Stockholders has averaged -$10.7 million across 5 years, with a median of -$13.9 million in 2024.
• Annual changes were most pronounced in 2021 — Net Income towards Common Stockholders plunged 24757.7% — and 2022, when it jumped 912.98%.
• Vicarious Surgical's Net Income towards Common Stockholders stood at $21.8 million in 2021, then slumped by 151.32% to -$11.2 million in 2022, then slipped by 17.27% to -$13.1 million in 2023, then dropped by 6.22% to -$13.9 million in 2024, then rose by 20.59% to -$11.1 million in 2025.
• Business Quant data shows RBOT's Net Income towards Common Stockholders at -$11.1 million in Q3 2025, -$13.2 million in Q2 2025, and -$15.4 million in Q1 2025.